TORNTPHARM Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > torntpharm

Technical Analysis

Technical Strength: 3.1 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 39.7. According to RSI analysis, torntpharm is weak. 3.0 TORNTPHARM RSI Chart
MACD (?) MACD: -7.88 and Signal Line: 0.336. According to MACD analysis, torntpharm is technically weak. 2.0 TORNTPHARM MACD Chart
Simple Moving Average (?) According to simple moving average analysis, torntpharm is facing resistance at 1.38e+03 and support level is at 1292.319. 3.0 TORNTPHARM Simple Moving Average Chart
Exponential Moving Average (?) Price just got above it's 200-day exponential moving average which is a positive signal. According to exponential moving average analysis, torntpharm is facing resistance at 1.37e+03 and support level is at 1331.673. 8.0 TORNTPHARM Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.19. According to bollinger bands, torntpharm is technically weak. 3.0 TORNTPHARM Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is below all levels. Resistance levels are 1349.1915 and 1373.175. Support level is 1271.55. 2.5 TORNTPHARM Fibonacci Retracement Chart
Average True Range (?) ATR: 44.8 NA TORNTPHARM Average True Range Chart
Average Directional Index (?) ADX is 17.3 which means TORNTPHARM is in a trading range and there is no trend. NA TORNTPHARM Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
February 23, 2018
Open Price 1323.0
High Price 1355.25
Low Price 1320.0
Close Price 1336.55
Absolute Change 14.35
Percentage Change 1.09%
Weekly Change -6.09%
Monthly Change -8%
Yearly Change 6.02%
52-week high 1575.25
52-week low 1141.95
Corporate Actions
ExDate Purpose
February 15, 2018 INT DIV RS 9/- PER SHARE
February 15, 2018 INTERIM DIVIDEND
June 19, 2017 DIV-RS 4 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.397
Confidence in Beta0.38%
Market Capital Rs. 22617.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 132.28
TTM Price-to-Earnings (P/E) Ratio 10.1
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 23 February 2018: Deliverable Quantity:3.08e+04 NA TORNTPHARM Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 23 February 2018: Daily Volatility:0.3019 NA TORNTPHARM Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 23 February 2018: PCR_OI:0 PCR:0 NA TORNTPHARM PCR Chart
Option Pain (?) 23 February 2018: Max Pain:1336.55 NA TORNTPHARM Option Pain Chart
Premium (?) 23 February 2018 Premium: 5.0 Futures OI:0 NA TORNTPHARM Premium Chart
Option_MAX_OI (?) 23 February 2018: Price:1336.55 Put with maximum OI:0.0 Call with maximum OI:1400.0 NA TORNTPHARM Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
March 28, 2018 1341.55 710000.0 326.0 392.0 1336.55

Announcements

February 12, 2018 Investor Presentation Torrent Pharmaceuticals Limited has informed the Exchange regarding Investor Presentation
February 09, 2018 Dividend Torrent Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on February 08, 2018 has declared An interim dividend of Rs 9 (180%) per equity share of Rs 5 fully paid up. The dividend is expected to be paid /dispatched on February 23, 2018.
See all Announcements

Board Meetings

Date Meeting Date Purpose
January 23, 2018 January 25, 2018 Raising of Funds to consider inter-alia the following: 1) Issue of Equity shares including Convertible Bonds/Debentures through Qualified Institutional Placement ( QIP) and /or Depository Receipts or any other modes. 2) Issue of Unsecured/Secured Redeemable Non-Convertible Debentures/Bonds by way of private placement.
January 23, 2018 February 08, 2018 Results/Dividend inter alia to consider and approve the Financial Results on Standalone and Consolidated basis of the Company for the quarter and nine months ended on December 31, 2017. 2) In the above meeting, the Board would also consider payment of Interim Dividend for the year 2017-18. 3) As per Regulation 42 of the Listing Regulations, the Company has fixed February 19, 2017,as the Record date for the purpose of payment of said Interim dividend, if declared by the board at their aforesaid meeting, payable to those shareholders whose name appears on the Register of Members or on records of National Securities Depositories Limited or Central Depositories Services ( India) Limited as beneficial owners as on said record date.
See all Board Meetings

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 1284 Rs. 1302 Rs. 1319 Rs. 1337 Rs. 1355 Rs. 1373 Rs. 1390